Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07236892 · ClinicalTrials.gov registry record · NA

Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants

A NA study of Movement Disorders and Neurorehabilitation, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07236892: Recruiting NA study of Movement Disorders and Neurorehabilitation, sponsored by University of California, Los Angeles.

NCT07236892 is a NA study of Movement Disorders and Neurorehabilitation that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 50 participants, below the 1,065-participant average among 26 other Movement Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07236892, a NA study of Movement Disorders and Neurorehabilitation, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Participants will perform experiments with non-invasive activity recordings. The study will record from multiple non-invasive signal sources that reflect motor intent that may include: electroencephalography (EEG), electromyography (EMG), functional near infrared spectroscopy (fNIRS), inertial measurement units (IMUs), eye movements, pupil size, and speech. Participants will wear all or a subset of these sensors and be asked to perform, imagine, or attempt movements or speech. The recorded sensor signals will be decoded to help guide an end effector, which may be a computer, robotic arm, wheelchair, or other assistive device. These experiments present minimal risk and participants may withdraw participation at any time for any reason. Participants may return for additional experiments if desired and to perform additional comparisons. If a participant withdraws during a comparison, another participant will be recruited to complete collection of data for that comparison.

Primary Outcome

The normalized performance of the non-invasive assistive interface on a task. Non-invasive signals, which may include electroencephalography, electromyography, functional near infrared spectroscopy, inertial measurements units, eye movements, pupil size, and speech are input into an algorithm that controls an end effector's movements. The end effector, which may be a computer cursor, robotic manipulator, wheelchair, or other assistive device, is used to perform a motor task. The normalized perfo

Interventions

  • BEHAVIORAL Participants will perform experimental tasks while undergoing non-invasive activity recordings, which may include EEG, EMG, IMUs, fNIRS, eye gaze, or pupillometry.

Study Locations (1)

California

  • UCLA Neural Engineering and Computation Lab - Los Angeles

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-11-26
Est. Completion 2029-12-01
Phase NA

What NCT07236892 shows while recruiting

NCT07236892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,065-participant average among 26 other Movement Disorders trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Movement Disorders appearing as the primary indexed condition, and to 1 intervention - of which Participants will perform experimental tasks while undergoing non-invasive activity recordings, which may include EEG, EMG, IMUs, fNIRS, eye gaze, or pupillometry. is the first listed.

NCT07236892 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07236892 about?

NCT07236892 is a clinical study titled "Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants". Participants will perform experiments with non-invasive activity recordings. The study will record from multiple non-invasive signal sources that reflect motor intent that may include: electroencephalography (EEG), electromyography (EMG), functional near infrared spectroscopy (fNIRS), inertial measu...

What is the current status of trial NCT07236892?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-26. Estimated completion is 2029-12-01.

What conditions does trial NCT07236892 study?

This clinical trial studies the following conditions: Movement Disorders, Neurorehabilitation, Non-invasive Activity Recording.

What interventions are being tested in trial NCT07236892?

The interventions under investigation include: Participants will perform experimental tasks while undergoing non-invasive activity recordings, which may include EEG, EMG, IMUs, fNIRS, eye gaze, or pupillometry. (BEHAVIORAL).

Who is sponsoring clinical trial NCT07236892?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07236892 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Movement Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07236892's enrollment target sits among peer trials

50 21st of 26 higher than 6 of 26 other Movement Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Movement Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07236892, the US trial registry maintained by the National Library of Medicine. NCT07236892 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.